WHO ICTRP trial

A Comparative Study of Tegileridine Fumarate versus Sufentanil for Postoperative…

ChiCTR2500113605 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500113605
Public title A Comparative Study of Tegileridine Fumarate versus Sufentanil for Postoperative Analgesia Following Laparoscopic Total Hysterectomy: A Prospective, Randomized, Double-Blind, Controlled Clinical Trial Focusing on Quality of Recovery as the Primary Endpoint.
Scientific title A Comparative Study of Tegileridine Fumarate versus Sufentanil for Postoperative Analgesia Following Laparoscopic Total Hysterectomy: A Prospective, Randomized, Double-Blind, Controlled Clinical Trial Focusing on Quality of Recovery as the Primary Endpoint.
Primary sponsor Liaocheng Second People's Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Countries China
Conditions Gynecological uterine diseases
Interventions Experimental group:Postoperative analgesia: Tigillitin fumarate is prepared at 0.05mg/ml;Control group:Postoperative analgesia: Sufentanil is prepared at 5ug/ml
Registration date Dec 1, 2025
Target size Experimental group:60;Control group:60
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations